Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDCL3 pseudogene 1 (PDCL3P1) is a processed pseudogene related to the phosducin-like 3 (PDCL3) encoding gene. Unlike the protein-coding parent gene, pseudogenes like PDCL3P1 typically lack functional protein products due to mutations or loss of regulatory elements. There is no strong evidence that PDCL3P1 itself produces protein or functions as a therapeutic target, biomarker, or participates in key biological functions or disease processes. Pseudogenes are generally "dead" genes; most lack the ability to code for functional proteins. Most scientific and clinical interest centers on the protein-coding parent gene PDCL3, which has been implicated as a novel oncogene and biomarker in glioma, and not on its pseudogenes. Therefore, PDCL3P1 is not considered a target for drugs, therapeutic monitoring, or clinical intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDCL3 pseudogene 1 (PDCL3P1).